National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

carboxyamidotriazole
An orally-active agent with potential antineoplastic activity. Carboxyamidotriazole binds to and inhibits non-voltage-operated Ca2+ channels, blocking both Ca2+ influx into cells and Ca2+ release from intracellular stores and resulting in the disruption of calcium channel-mediated signal transduction and inhibition of vascular endothelial growth factor (VEGF) signaling, endothelial proliferation, and angiogenesis. This agent may also inhibit tumor cell growth, invasion and metastasis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:carboxyamido-triazole
carboxyaminoimidazole
Abbreviation:CAI
Code name:L651582
Chemical structure names:
  • 1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4(4-chlorobenzoyl)phenyl)methyl)
  • 5-Amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide



Previous:caracemide, carbamazepine, carbogen, carbon-11 acetate, carboplatin
Next:carboxyphenyl retinamide, carcinoembryonic antigen peptide 1, carcinoembryonic antigen peptide 1-6D, carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine, Cardizem

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov